Convenience and Cost Capsules: No needles or sterile technique required
Ways to Watch & Listen Discover Financial Issues live each weekday or on-demandavailable on web, mobile app, Roku, Fire TV, social media, and radio
In a double-blind study of n=16 chronic insomniac patients, intravenous DSIP at 25 nmol/kg over 3 nights was associated with higher sleep efficiency and shorter sleep latency (the time it takes to fall asleep) compared with placebo, but the effects were described as weak [4]
A provider can help review: Whether BPC-157 is appropriate for your situation Whether another peptide or regenerative option may be safer Possible medication or health-history concerns Route of use and cycle length Sterility and sourcing concerns Whether follow-up monitoring is needed When to stop, pause, or adjust the plan Medical guidance matters because peptide therapy should be personalized, monitored, and tied to a real treatment goal